Lower Drug Costs for Families Act

This bill would require drug companies to pay rebates on certain expensive brand-name prescription drugs sold through private health insurance if the prices of those drugs go up faster than inflation. Right now, a similar rule already exists for drugs covered by Medicare, and this bill would extend that rule to the private insurance market as well. Drug companies that don't follow these rules could face financial penalties. The bill also changes the starting year used to calculate the rebates from 2021 to 2016.

Your Vote